Hints and tips:
Related Special Reports
...The company is also a partner for several pharmaceutical companies....
...Fruergaard Jorgensen also said that Novo Nordisk’s efforts to develop some of its oral drugs would require much more active pharmaceutical ingredient than injectables....
...Meanwhile, the contract manufacturing sector is poised to grow faster than the pharma sector at large over the next four years, according to pharmaceutical analytics firm Evaluate....
...Lab monkey prices in China have plummeted as a post-pandemic slowdown in drug development ripples through the pharmaceutical sector in the world’s second-largest economy....
...AstraZeneca has acquired oncology biotech Fusion Pharmaceuticals for $2.4bn to build its expertise and challenge Swiss company Novartis in the developing field of a more targeted form of radiotherapy....
...Ireland’s economy has officially entered recession after contracting by 1.9 per cent in the third quarter, pushed lower by a drop in pharmaceutical exports....
...Pharmaceutical companies also have a key role to play in providing affordable access to these essential products. The global industry’s response to date has been inadequate and fragmented....
...The Association of the British Pharmaceutical Industry, the drugmakers’ trade body, said it supported “this tough deal” even though the agreement would continue to restrict pharmaceutical companies’ sales...
...Avid Bioservices, a small-cap company that helps develop and manufacture drugs for pharmaceutical companies, filed this with the SEC yesterday: On February 29, 2024, Avid Bioservices, Inc....
...This is an audio transcript of the Behind the Money podcast episode: ‘Ozempic’s unconventional origins’ Michela Tindera It’s November, and the FT’s global pharmaceutical editor Hannah Kuchler is in Copenhagen...
...GLP-1s now underpin a weight loss drug, Wegovy, developed by pharmaceutical group Novo Nordisk....
...communique issued on Wednesday, the party’s deeply feared internal watchdog, the Central Commission for Discipline Inspection, said it would prioritise investigation into the finance, agricultural and pharmaceutical...
...Novo Nordisk purchased Dicerna Pharmaceuticals, a company focused in RNA-based therapeutics, for $3.3bn in 2021....
...The pharmaceutical industry is close to agreeing a deal with the UK government over drug pricing, according to the chief financial officer of Swiss drugmaker Novartis....
...An Indian pharmaceutical manufacturer, Intas, is a major supplier of finished dosage methotrexate to the US through its subsidiary Accord Healthcare....
...Cheaper valuations have finally drawn cash-rich pharmaceutical makers back to biotechs. Their aim, as always, is to replenish their drug pipelines affordably. Relief is sorely needed....
...It needs further deals to replenish its pharmaceuticals pipeline....
...The former Roche pharmaceuticals boss took on one of the most unenviable jobs in corporate Europe last June....
...Pharmaceutical products such as medicines, vaccines and diagnostics can be protected by several types of intellectual property, including patents and trade secrets....
...But after years of trying, the pharmaceuticals industry is getting to grips with the multibillion-dollar problem of fatty liver disease....
...WuXi AppTec is a major supplier of essential ingredients to many of the largest global pharmaceutical companies and conducts drug development for them....
...referred to in the essay albeit not by name, Samuel P Huntington wrote that “if civilisation is what counts . . . violence between Ukrainians and Russians is unlikely”, being two Slavic, primarily Orthodox...
...German pharmaceutical glassware company Schott Pharma should receive a warm reception when it joins the Frankfurt Stock Exchange later this year....
...Joseph Dupont, then a vice-president at Alexion Pharmaceuticals, now owned by AstraZeneca, shared knowledge of an upcoming acquisition of Portola Pharmaceuticals with Shawn Cronin, a childhood friend and...
...The country is home to the third-largest pharmaceutical market in the world. There is still room for growth in Japan’s $53bn dispensing pharmacy market....
International Edition